CVAC System / SURE Procedure
Kidney Stone Treatment (Nephrolithiasis)
Key Facts
About Calyxo
Calyxo is a commercial-stage medical device company targeting the significant clinical and economic burden of kidney stone disease. Its flagship product, the CVAC System, integrates laser lithotripsy, irrigation, dynamic aspiration, and stone collection into a single platform to perform the proprietary SURE (Steerable Ureteroscopic Renal Evacuation) Procedure. The company, led by a seasoned team with prior successful exits in urology, is positioned to capture market share in the global kidney stone management sector by addressing the unmet need for reliable, single-procedure stone clearance. Calyxo is currently in the commercial launch phase, supported by clinical evidence from a randomized controlled trial.
View full company profile